Favorable pleiotropic effects of sodium glucose cotransporter 2 inhibitors: head-to-head comparisons with dipeptidyl peptidase-4 inhibitors in type 2 diabetes patients.
Shih-Chieh ShaoKai-Cheng ChangSwu-Jane LinRong-Nan ChienMing-Jui HungYuk-Ying ChanYea-Huei Kao YangEdward Chia-Cheng LaiPublished in: Cardiovascular diabetology (2020)
SGLT2 inhibitors had glucose-lowering effects comparable to those of DPP4 inhibitors but more favorable pleiotropic effects on body weight, ALT and eGFR changes, potentially improving type 2 diabetes patients' cardio-metabolic disease risks.